Literature DB >> 22751094

Rapidly developing myomatous erythrocytosis syndrome: a case report.

Jyothi Padavala1, Amin Abdelmagied, Simon Emery.   

Abstract

Myomatous erythrocytosis syndrome is polycythaemia associated with uterine leiomyoma, a rare condition known for over five decades with unclear aetiology. The present case is a 51-year-old Caucasian woman who presented with urinary retention and anaemia secondary to multiple uterine fibroids and menorrhagia 5 years following uterine artery embolisation. She opted for abdominal hysterectomy but preoperatively was found to be polycythaemic with haemoglobin of 23 g% and raised serum erythropoietin requiring serial venesections. At a year postoperatively she maintains normal haemoglobin and serum erythropoietin levels. Ectopic production of erythropoietin by fibroids is the most favoured aetiopathogenesis in this case. However, the rapid transition from anaemia to polycythaemia in 5 months is a striking feature as fibroid-linked polycythaemia has so far been reported on presentation. Vigilance is crucial in excluding polycythaemia while such patients are on waiting list as there is a risk of thromboembolism, which is further increased by surgery.

Entities:  

Mesh:

Year:  2010        PMID: 22751094      PMCID: PMC3047493          DOI: 10.1136/bcr.11.2009.2443

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  5 in total

1.  Polycythemia associated with leiomyoma of the uterus.

Authors:  R Raj; Y Lake
Journal:  Br J Obstet Gynaecol       Date:  1992-11

2.  Erythropoietin synthesis by tumour tissues in a patient with uterine myoma and erythrocytosis.

Authors:  M Suzuki; S Takamizawa; K Nomaguchi; S Suzu; M Yamada; T Igarashi; I Sato
Journal:  Br J Haematol       Date:  2001-04       Impact factor: 6.998

Review 3.  Giant uterine fibromyoma producing secondary polycythemia.

Authors:  C L Clark; T O Wilson; T E Witzig
Journal:  Obstet Gynecol       Date:  1994-10       Impact factor: 7.661

4.  Myomatous erythrocytosis syndrome: further proof for the pathogenic role of erythropoietin.

Authors:  L T Vlasveld; C W M de Wit; R A Verweij; A Castel; P M Jansen; A A W Peters
Journal:  Neth J Med       Date:  2008 Jul-Aug       Impact factor: 1.422

5.  JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis.

Authors:  Linda M Scott; Wei Tong; Ross L Levine; Mike A Scott; Philip A Beer; Michael R Stratton; P Andrew Futreal; Wendy N Erber; Mary Frances McMullin; Claire N Harrison; Alan J Warren; D Gary Gilliland; Harvey F Lodish; Anthony R Green
Journal:  N Engl J Med       Date:  2007-02-01       Impact factor: 91.245

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.